EUVIMEDEUVIMED entdecken
Open Access

Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension

Monica Mukherjee, Vivek P Jani, Ryan Osgueritchian, Hoda Mombeini, Aiden Abidov, Gerald Beck, Serpil Erzurum, Robert P Frantz, Paul M Hassoun, Anna R Hemnes, Nicholas S Hill, Evelyn M Horn und 14 weitere

CHEST · 2025

DOI: 10.1016/j.chest.2025.04.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CHEST, 2025. Verfasst von Monica Mukherjee und 25 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: mmukher2@jhu.edu. Hauptthemen laut MEDLINE: Echocardiography, Pulmonary Arterial Hypertension, Hypertension, Pulmonary, Heart Ventricles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Scleroderma Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Echocardiographic metrics of right ventricular (RV) chamber size and function enhance prognostication, risk stratification, and measurement of therapeutic response in patients with pulmonary arterial hypertension (PAH), though the most effective metrics remain unclear. RESEARCH QUESTION: In a well-phenotyped cohort of patients with incident and prevalent PAH, can qualitative grades of RV echocardiographic function be established based on their association with functional outcomes, and do they demonstrate prognostic value beyond traditional risk scores? STUDY DESIGN AND METHODS: In the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics (PVDOMICS) program, 405 (prevalent, n = 336; incident, n = 69) participants were investigated. Multivariable linear regression examined associations with 6-minute walk distance and the Comparative Prospective Registry for Newly Initiated Therapies (COMPERA) and the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) Lite 2.0 PAH risk scores. Penalized Cox regression was used to develop new models combining prior risk score variables with echo parameters. Cluster analysis combined with survival analysis adjusting for potential confounders was used to demonstrate prognostic significance. RESULTS: In both incident and prevalent PAH, reduced RV function was associated with increased N-terminal pro-B-type natriuretic peptide levels, reduced 6-minute walk distance, and increased COMPERA and REVEAL Lite 2.0 risk scores after adjusting for duration of PAH and relevant confounders. The addition of echocardiographic variables to models incorporating the COMPERA and REVEAL 2.0 scores yielded a 10% increase in the C-statistic. The severe RV dysfunction group was associated with increased all-cause mortality, with up to a threefold increase in mortality in multivariable models adjusted for relevant confounders, PAH duration, and invasive pulmonary vascular resistance. INTERPRETATION: Our results show that reduced RV function on echocardiography in PAH is associated with worsened outcomes in incident and prevalent PAH. Echocardiographic assessment of RV function provided additional value to existing PH risk prediction scores and invasive hemodynamics. Furthermore, defining severity of RV function through cluster analysis has important implications for risk prognostication, with potential application to monitor response to therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EchocardiographyPulmonary Arterial HypertensionHypertension, PulmonaryHeart VentriclesVentricular Dysfunction, RightHumansFemaleMaleMiddle AgedPrognosisRisk AssessmentProspective StudiesRegistriesPhenomicsAgedVentricular Function, RightWalk TestPeptide Fragments

Stichwörter der Autor:innen

echocardiographymortalitypulmonary hypertensionright heart

Substanzen

Peptide Fragments

Autor:innen und Institutionen

  • Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: mmukher2@jhu.edu.
  • Johns Hopkins University School of Medicine, Baltimore, MD.
  • Wayne State University, Detroit, MI.
  • Cleveland Clinic, Cleveland, OH.
  • Mayo Clinic Division of Cardiology, Rochester, MN.
  • Vanderbilt University School of Medicine, Nashville, TN.

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Scleroderma Foundation
  • National Heart Lung and Blood Institute Division of Intramural Research
  • Pulmonary Hypertension Association
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute
  • U.S. Department of Defense

Zitieren

APA

Mukherjee, M., Jani, V. P., Osgueritchian, R., Mombeini, H., Abidov, A., Beck, G., Erzurum, S., Frantz, R. P., Hassoun, P. M., Hemnes, A. R., Hill, N. S., Horn, E. M., Kim, J., Kwon, D., Larive, A. B., Leary, P. J., Leopold, J. A., Mathai, S. C., Mehra, R., …, & Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics Network (2025). Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension. CHEST. https://doi.org/10.1016/j.chest.2025.04.007

Vancouver

Mukherjee M, Jani VP, Osgueritchian R, Mombeini H, Abidov A, Beck G, et al. Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension. CHEST. 2025. doi:10.1016/j.chest.2025.04.007

BibTeX
@article{Mukherjee2025,
  author = {Mukherjee, Monica and Jani, Vivek P and Osgueritchian, Ryan and Mombeini, Hoda and Abidov, Aiden and Beck, Gerald and Erzurum, Serpil and Frantz, Robert P and Hassoun, Paul M and Hemnes, Anna R and Hill, Nicholas S and Horn, Evelyn M and Kim, Jiwon and Kwon, Deborah and Larive, A Brett and Leary, Peter J and Leopold, Jane A and Mathai, Stephen C and Mehra, Reena and Park, Margaret M and Rosenzweig, Erika B and Tang, W H Wilson and Jellis, Christine L and Rischard, Franz P and Badagliacca, Roberto and Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics Network, Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics Network},
  title = {Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension},
  journal = {CHEST},
  year = {2025},
  doi = {10.1016/j.chest.2025.04.007}
}
Kostenlos starten →